As of 2026-03-23, the Relative Valuation of Haemonetics Corp (HAE) is 89.15 USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.58 USD, the upside of Haemonetics Corp based on Relative Valuation is 52.2%.
The range of the Relative Valuation is 73.66 - 116.66 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.1x - 30.9x | 26.0x |
| Forward P/E multiples | 18.2x - 21.4x | 19.8x |
| Fair Price | 73.66 - 116.66 | 89.15 |
| Upside | 25.7% - 99.1% | 52.2% |
| Date | P/E |
| 2026-03-20 | 15.52 |
| 2026-03-19 | 15.60 |
| 2026-03-18 | 15.77 |
| 2026-03-17 | 15.91 |
| 2026-03-16 | 15.81 |
| 2026-03-13 | 15.87 |
| 2026-03-12 | 15.76 |
| 2026-03-11 | 16.06 |
| 2026-03-10 | 16.65 |
| 2026-03-09 | 17.01 |
| 2026-03-06 | 16.99 |
| 2026-03-05 | 17.01 |
| 2026-03-04 | 17.13 |
| 2026-03-03 | 17.38 |
| 2026-03-02 | 16.92 |
| 2026-02-27 | 16.77 |
| 2026-02-26 | 16.49 |
| 2026-02-25 | 16.51 |
| 2026-02-24 | 16.34 |
| 2026-02-23 | 16.23 |
| 2026-02-20 | 16.21 |
| 2026-02-19 | 16.07 |
| 2026-02-18 | 16.06 |
| 2026-02-17 | 15.52 |
| 2026-02-13 | 15.30 |
| 2026-02-12 | 15.27 |
| 2026-02-11 | 15.23 |
| 2026-02-10 | 15.75 |
| 2026-02-09 | 15.28 |
| 2026-02-06 | 15.72 |
| 2026-02-05 | 17.22 |
| 2026-02-04 | 17.47 |
| 2026-02-03 | 17.18 |
| 2026-02-02 | 17.42 |
| 2026-01-30 | 17.66 |
| 2026-01-29 | 17.47 |
| 2026-01-28 | 17.50 |
| 2026-01-27 | 17.98 |
| 2026-01-26 | 18.11 |
| 2026-01-23 | 18.23 |
| 2026-01-22 | 18.55 |
| 2026-01-21 | 18.57 |
| 2026-01-20 | 18.57 |
| 2026-01-16 | 19.12 |
| 2026-01-15 | 19.60 |
| 2026-01-14 | 20.06 |
| 2026-01-13 | 20.88 |
| 2026-01-12 | 21.96 |
| 2026-01-09 | 21.73 |
| 2026-01-08 | 22.26 |